Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jose Osorio Filho

Clinical Cardiac Electrophysiology Miami, FL Medical Doctor

NPI 1821201690 CMS profile 83337

3659 S Miami Ave Ste 4008, Miami, FL 33133

Open in the dashboard

General payments

$1,223,380

1,358 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$462,483

2 holdings reported · through program year 2025

Research they led as principal investigator

$14,699,874 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Jose Osorio Filho of Miami, FL is reported in the CMS Open Payments database as having received $1,223,380 across 1,358 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $14,699,874 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $462,483 across 2 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $82,332 112
2024 General $161,478 164
2023 General $183,222 245
2022 General $185,048 275
2021 General $178,501 183
2020 General $212,825 140
2019 General $219,976 239
2025 Ownership $462,483 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jose Osorio Filho
  • Clinical Cardiac Electrophysiology median
  • Middle half of Clinical Cardiac Electrophysiology
  • National median

In program year 2025, general payments to Jose Osorio Filho were reported at $82,332. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.

Show as a table
Year Jose Osorio Filho Clinical Cardiac Electrophysiology median Middle half National median
2019 $219,976 $2,361 $585–$8,260 $163
2020 $212,825 $993 $247–$4,351 $114
2021 $178,501 $1,185 $326–$4,739 $132
2022 $185,048 $2,073 $554–$6,789 $149
2023 $183,222 $2,568 $759–$8,159 $160
2024 $161,478 $2,557 $703–$7,403 $164
2025 $82,332 $2,462 $733–$7,710 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medical Device Business Services, Inc. $500,858 227 payments
  2. Boston Scientific Corporation $333,380 342 payments
  3. Biosense Webster, Inc. $244,427 431 payments
  4. Abbott Laboratories $62,829 134 payments
  5. Medtronic, Inc. $35,929 71 payments
  6. Volta Medical Inc $26,392 24 payments
  7. Philips Electronics North America Corporation $5,383 8 payments
  8. E.R. Squibb & Sons, L.L.C. $4,651 6 payments
  9. Siemens Medical Solutions USA, Inc. $3,197 3 payments
  10. Medtronic Vascular, Inc. $2,284 17 payments
  11. Other $4,050 95 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $847,325 308 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $215,981 71 payments
  3. Travel and Lodging $114,609 142 payments
  4. Food and Beverage $42,591 829 payments
  5. Honoraria $2,836 6 payments
  6. Education $37 2 payments
Products named General payments · program years 2019–2025
  1. Carto 3 System $379,195 235 payments
  2. Carto 3 $361,691 399 payments
  3. ENSITE $38,647 47 payments
  4. FARAPULSE $36,183 28 payments
  5. WATCHMAN Structural Heart $32,018 44 payments
  6. VX1 $22,939 18 payments
  7. WATCHMAN Access System $17,007 44 payments
  8. WATCHMAN Structural Heart $16,022 19 payments
  9. ENSITE PRECISION $13,879 42 payments
  10. General - Therapies $12,249 18 payments
  11. Other $78,020 317 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 13 drugs

Part D claims

388

Median for Clinical Cardiac Electrophysiology: 1,090

Drug cost

$161,404

Median for Clinical Cardiac Electrophysiology: $354,841

Branded share of claims

48.7%

Median for Clinical Cardiac Electrophysiology: 38.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 134 $114,579
Xarelto Rivaroxaban Brand 30 $29,742
Entresto Sacubitril/Valsartan Brand 14 $13,654
Amiodarone Hcl Generic 22 $1,256
Flecainide Acetate Generic 15 $791
Metoprolol Succinate Generic 28 $403
Nadolol Generic 20 $341
Carvedilol Generic 42 $210
Losartan Potassium Generic 18 $184
Lisinopril Generic 21 $114

The 10 drugs with the highest cost, of 13 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,573 Part D prescribers listed as Clinical Cardiac Electrophysiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 28 billing codes

Paid by Medicare

$42,804

Medicare's payments for the services billed

Medicare patients

57

Average age 75

Services billed

232

29 women, 28 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Atrial fibrillation 75%
Ischemic heart disease 61%
Arthritis 46%
Heart failure 42%
Diabetes 37%
Chronic kidney disease 28%
Depression 23%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

3 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
ELIQUIS
$26 134 —
CAMZYOS
$26 — —
XARELTO
$19 30 —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

1,358 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Cardiac Electrophysiology in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record